Lonza Group AG (LZAGF)
OTCMKTS
· Delayed Price · Currency is USD
649.05
-4.22 (-0.65%)
Feb 21, 2025, 3:44 PM EST
Lonza Group AG Revenue
In the year 2024, Lonza Group AG had annual revenue of 6.57B CHF, down -2.13%. Lonza Group AG had revenue of 3.52B in the half year ending December 31, 2024, with 8.52% growth.
Revenue
6.57B CHF
Revenue Growth
-2.13%
P/S Ratio
n/a
Revenue / Employee
351.81K CHF
Employees
18,686
Market Cap
46.87B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.57B | -143.00M | -2.13% |
Dec 31, 2023 | 6.72B | 494.00M | 7.94% |
Dec 31, 2022 | 6.22B | 814.00M | 15.05% |
Dec 31, 2021 | 5.41B | 901.00M | 19.99% |
Dec 31, 2020 | 4.51B | 301.00M | 7.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
SANUWAVE Health | 29.30M |
Lonza Group AG News
- 19 days ago - Lonza Group Appears To Be Fully Valued At This Time (Rating Downgrade) - Seeking Alpha
- 26 days ago - Lonza Posts Lower Sales, Earnings But Expects Capsules Business Rebound This Year - The Wall Street Journal
- 4 months ago - Lonza Sees Accelerating Sales Growth in Final Quarter - The Wall Street Journal
- 5 months ago - Acumen Pharmaceuticals extends collaboration with Lonza - Seeking Alpha
- 5 months ago - Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer's Disease - Benzinga
- 7 months ago - Lonza Group AG (LZAGY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 10 months ago - Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Lonza: Acceleration In Mid-Term Sales Growth - Seeking Alpha